Reuters logo
BRIEF-Bayer says to invest more than 500 million euros for the manufacturing of hemophilia a products currently in development
March 11, 2014 / 2:35 PM / 4 years ago

BRIEF-Bayer says to invest more than 500 million euros for the manufacturing of hemophilia a products currently in development

FRANKFURT, March 11 (Reuters) - Bayer AG says: * to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development Expansion of manufacturing capacities for innovative therapy options

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below